25 XP   0   0   10

Biosyntech Inc
Buy, Hold or Sell?

Let's analyse Biosyntech Inc together

PenkeI guess you are interested in Biosyntech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biosyntech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biosyntech Inc

I send you an email if I find something interesting about Biosyntech Inc.

Quick analysis of Biosyntech Inc (30 sec.)










What can you expect buying and holding a share of Biosyntech Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$-0.06
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.05
Return On Investment
-1,795.8%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.003 - $0.003
How sure are you?
50%

1. Valuation of Biosyntech Inc (5 min.)




Live pricePrice per Share (EOD)

$0.00

2. Growth of Biosyntech Inc (5 min.)




Is Biosyntech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$605.5k$962.7k-$1.5m-259.0%

How much money is Biosyntech Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.1m-$5.3m$4.2m358.0%
Net Profit Margin-31,739.1%-3,383.8%--

How much money comes from the company's main activities?

3. Financial Health of Biosyntech Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Biosyntech Inc? (5 min.)

Welcome investor! Biosyntech Inc's management wants to use your money to grow the business. In return you get a share of Biosyntech Inc.

What can you expect buying and holding a share of Biosyntech Inc?

First you should know what it really means to hold a share of Biosyntech Inc. And how you can make/lose money.

Speculation

The Price per Share of Biosyntech Inc is $0.003. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biosyntech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biosyntech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biosyntech Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-2,715.7%-0.08-2,715.7%-0.06-1,945.5%-0.05-1,560.6%-0.04-1,198.8%
Usd Book Value Change Per Share-0.01-449.0%-0.01-449.0%-0.01-357.9%0.00-44.4%0.00-21.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-449.0%-0.01-449.0%-0.01-357.9%0.00-44.4%0.00-21.7%
Usd Price Per Share0.13-0.13-0.25-0.35-0.39-
Price to Earnings Ratio-1.53--1.53--4.28--4.70--12.63-
Price-to-Total Gains Ratio-9.28--9.28--23.29-2.23--2.84-
Price to Book Ratio-24.04--24.04-30.24-0.20-41.57-
Price-to-Total Gains Ratio-9.28--9.28--23.29-2.23--2.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.003
Number of shares333333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (333333 shares)-4,489.53-444.38
Gains per Year (333333 shares)-17,958.12-1,777.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-17958-179680-1778-1788
20-35916-359260-3555-3566
30-53874-538840-5333-5344
40-71832-718420-7110-7122
50-89791-898000-8888-8900
60-107749-1077580-10665-10678
70-125707-1257160-12443-12456
80-143665-1436740-14220-14234
90-161623-1616320-15998-16012
100-179581-1795900-17775-17790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.01.00.0%0.07.01.00.0%0.07.01.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.05.00.037.5%3.05.00.037.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.05.00.037.5%3.05.00.037.5%

Fundamentals of Biosyntech Inc

About Biosyntech Inc

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company's products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials. In addition, it manufactures ultra pure chitosans under the Ultrasan name; and offers manufacturing and analytical services. The company was incorporated in 1994 and is based in Laval, Canada. On May 12, 2010, Biosyntech Inc. filed for administration under the Bankruptcy and Insolvency Act. Biosyntech Inc. is in reorganization.

Fundamental data was last updated by Penke on 2024-05-15 00:54:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.

1.1. Profitability of Biosyntech Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biosyntech Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biosyntech Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -31,739.1% means that $-317.39 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biosyntech Inc:

  • The MRQ is -31,739.1%. The company is making a huge loss. -2
  • The TTM is -31,739.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-31,739.1%TTM-31,739.1%0.0%
TTM-31,739.1%YOY-3,383.8%-28,355.3%
TTM-31,739.1%5Y-9,920.2%-21,819.0%
5Y-9,920.2%10Y-7,100.5%-2,819.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-31,739.1%-174.3%-31,564.8%
TTM-31,739.1%-210.4%-31,528.7%
YOY-3,383.8%-266.3%-3,117.5%
5Y-9,920.2%-408.9%-9,511.3%
10Y-7,100.5%-552.3%-6,548.2%
1.1.2. Return on Assets

Shows how efficient Biosyntech Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biosyntech Inc to the Biotechnology industry mean.
  • -179.7% Return on Assets means that Biosyntech Inc generated $-1.80 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biosyntech Inc:

  • The MRQ is -179.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -179.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-179.7%TTM-179.7%0.0%
TTM-179.7%YOY-151.5%-28.2%
TTM-179.7%5Y-85.4%-94.3%
5Y-85.4%10Y-84.0%-1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-179.7%-11.9%-167.8%
TTM-179.7%-11.6%-168.1%
YOY-151.5%-11.0%-140.5%
5Y-85.4%-13.1%-72.3%
10Y-84.0%-14.4%-69.6%
1.1.3. Return on Equity

Shows how efficient Biosyntech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biosyntech Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biosyntech Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biosyntech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-559.8%+559.8%
TTM-5Y-142.4%+142.4%
5Y-142.4%10Y-246.4%+104.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.3%+15.3%
TTM--14.7%+14.7%
YOY-559.8%-13.6%-546.2%
5Y-142.4%-17.7%-124.7%
10Y-246.4%-19.2%-227.2%

1.2. Operating Efficiency of Biosyntech Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biosyntech Inc is operating .

  • Measures how much profit Biosyntech Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biosyntech Inc to the Biotechnology industry mean.
  • An Operating Margin of -157,100.1% means the company generated $-1,571.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biosyntech Inc:

  • The MRQ is -157,100.1%. The company is operating very inefficient. -2
  • The TTM is -157,100.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-157,100.1%TTM-157,100.1%0.0%
TTM-157,100.1%YOY-4,216.1%-152,883.9%
TTM-157,100.1%5Y-42,937.6%-114,162.5%
5Y-42,937.6%10Y-27,716.7%-15,220.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-157,100.1%-332.1%-156,768.0%
TTM-157,100.1%-220.9%-156,879.2%
YOY-4,216.1%-281.8%-3,934.3%
5Y-42,937.6%-408.0%-42,529.6%
10Y-27,716.7%-521.7%-27,195.0%
1.2.2. Operating Ratio

Measures how efficient Biosyntech Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 196.26 means that the operating costs are $196.26 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biosyntech Inc:

  • The MRQ is 196.260. The company is inefficient in keeping operating costs low. -1
  • The TTM is 196.260. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ196.260TTM196.2600.000
TTM196.260YOY34.807+161.453
TTM196.2605Y78.613+117.647
5Y78.61310Y56.161+22.452
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ196.2603.003+193.257
TTM196.2603.246+193.014
YOY34.8073.619+31.188
5Y78.6135.190+73.423
10Y56.1616.874+49.287

1.3. Liquidity of Biosyntech Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biosyntech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.45 means the company has $0.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biosyntech Inc:

  • The MRQ is 0.450. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.450. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.450TTM0.4500.000
TTM0.450YOY2.044-1.594
TTM0.4505Y2.377-1.927
5Y2.37710Y2.511-0.135
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4503.814-3.364
TTM0.4504.158-3.708
YOY2.0445.253-3.209
5Y2.3776.098-3.721
10Y2.5116.434-3.923
1.3.2. Quick Ratio

Measures if Biosyntech Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biosyntech Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.11 means the company can pay off $0.11 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biosyntech Inc:

  • The MRQ is 0.113. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.113. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.1130.000
TTM0.113YOY0.464-0.351
TTM0.1135Y0.508-0.395
5Y0.50810Y0.662-0.154
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1133.246-3.133
TTM0.1133.837-3.724
YOY0.4645.195-4.731
5Y0.5085.929-5.421
10Y0.6626.351-5.689

1.4. Solvency of Biosyntech Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biosyntech Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biosyntech Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.92 means that Biosyntech Inc assets are financed with 192.5% credit (debt) and the remaining percentage (100% - 192.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biosyntech Inc:

  • The MRQ is 1.925. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.925. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.925TTM1.9250.000
TTM1.925YOY0.729+1.196
TTM1.9255Y0.952+0.973
5Y0.95210Y0.761+0.191
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9250.344+1.581
TTM1.9250.342+1.583
YOY0.7290.279+0.450
5Y0.9520.366+0.586
10Y0.7610.380+0.381
1.4.2. Debt to Equity Ratio

Measures if Biosyntech Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biosyntech Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biosyntech Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2.694-2.694
TTM-5Y5.412-5.412
5Y5.41210Y4.752+0.660
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.398-0.398
TTM-0.415-0.415
YOY2.6940.353+2.341
5Y5.4120.446+4.966
10Y4.7520.469+4.283

2. Market Valuation of Biosyntech Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biosyntech Inc generates.

  • Above 15 is considered overpriced but always compare Biosyntech Inc to the Biotechnology industry mean.
  • A PE ratio of -1.53 means the investor is paying $-1.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biosyntech Inc:

  • The EOD is -0.037. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.534. Based on the earnings, the company is expensive. -2
  • The TTM is -1.534. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.037MRQ-1.534+1.497
MRQ-1.534TTM-1.5340.000
TTM-1.534YOY-4.283+2.749
TTM-1.5345Y-4.700+3.166
5Y-4.70010Y-12.630+7.930
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.037-2.359+2.322
MRQ-1.534-2.548+1.014
TTM-1.534-2.742+1.208
YOY-4.283-3.936-0.347
5Y-4.700-6.316+1.616
10Y-12.630-6.544-6.086
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biosyntech Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.283+3.283
TTM--3.529+3.529
YOY--5.188+5.188
5Y--8.080+8.080
10Y--8.660+8.660
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biosyntech Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -24.04 means the investor is paying $-24.04 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biosyntech Inc:

  • The EOD is -0.577. Based on the equity, the company is expensive. -2
  • The MRQ is -24.036. Based on the equity, the company is expensive. -2
  • The TTM is -24.036. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.577MRQ-24.036+23.459
MRQ-24.036TTM-24.0360.000
TTM-24.036YOY30.237-54.273
TTM-24.0365Y0.200-24.236
5Y0.20010Y41.567-41.367
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.5772.094-2.671
MRQ-24.0362.032-26.068
TTM-24.0362.065-26.101
YOY30.2372.688+27.549
5Y0.2003.692-3.492
10Y41.5674.085+37.482
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biosyntech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.013-0.0130%-0.011-20%-0.001-90%-0.001-95%
Book Value Per Share---0.005-0.0050%0.008-163%0.005-199%0.009-158%
Current Ratio--0.4500.4500%2.044-78%2.377-81%2.511-82%
Debt To Asset Ratio--1.9251.9250%0.729+164%0.952+102%0.761+153%
Debt To Equity Ratio----0%2.694-100%5.412-100%4.752-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.081-0.0810%-0.058-28%-0.047-43%-0.036-56%
Gross Profit Margin--1.0001.0000%1.0000%0.800+25%0.875+14%
Market Cap349323.000-4067%14555125.00014555125.0000%29110250.000-50%40405027.000-64%45557541.250-68%
Net Profit Margin---317.391-317.3910%-33.838-89%-99.202-69%-71.005-78%
Operating Margin---1571.001-1571.0010%-42.161-97%-429.376-73%-277.167-82%
Operating Ratio--196.260196.2600%34.807+464%78.613+150%56.161+249%
Pb Ratio-0.577+98%-24.036-24.0360%30.237-179%0.200-12110%41.567-158%
Pe Ratio-0.037+98%-1.534-1.5340%-4.283+179%-4.700+206%-12.630+723%
Price Per Share0.003-4067%0.1250.1250%0.250-50%0.347-64%0.391-68%
Price To Free Cash Flow Ratio----0%-0%-0%-0%
Price To Total Gains Ratio-0.223+98%-9.281-9.2810%-23.286+151%2.228-517%-2.842-69%
Quick Ratio--0.1130.1130%0.464-76%0.508-78%0.662-83%
Return On Assets---1.797-1.7970%-1.515-16%-0.854-52%-0.840-53%
Return On Equity----0%-5.5980%-1.4240%-2.4640%
Total Gains Per Share---0.013-0.0130%-0.011-20%-0.001-90%-0.001-95%
Usd Book Value---605561.406-605561.4060%962736.428-163%611032.515-199%1052519.543-158%
Usd Book Value Change Per Share---0.013-0.0130%-0.011-20%-0.001-90%-0.001-95%
Usd Book Value Per Share---0.005-0.0050%0.008-163%0.005-199%0.009-158%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.081-0.0810%-0.058-28%-0.047-43%-0.036-56%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Market Cap349323.000-4067%14555125.00014555125.0000%29110250.000-50%40405027.000-64%45557541.250-68%
Usd Price Per Share0.003-4067%0.1250.1250%0.250-50%0.347-64%0.391-68%
Usd Profit---1176737.433-1176737.4330%-5389572.136+358%-1881889.868+60%-1956573.402+66%
Usd Revenue--3707.5283707.5280%159274.759-98%66029.568-94%76513.862-95%
Usd Total Gains Per Share---0.013-0.0130%-0.011-20%-0.001-90%-0.001-95%
 EOD+2 -5MRQTTM+0 -0YOY+5 -215Y+5 -2210Y+5 -22

3.2. Fundamental Score

Let's check the fundamental score of Biosyntech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.037
Price to Book Ratio (EOD)Between0-1-0.577
Net Profit Margin (MRQ)Greater than0-317.391
Operating Margin (MRQ)Greater than0-1,571.001
Quick Ratio (MRQ)Greater than10.113
Current Ratio (MRQ)Greater than10.450
Debt to Asset Ratio (MRQ)Less than11.925
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.797
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Biosyntech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.003
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2009-03-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets893
Total Liabilities1,719
Total Stockholder Equity-826
 As reported
Total Liabilities 1,719
Total Stockholder Equity+ -826
Total Assets = 893

Assets

Total Assets893
Total Current Assets5,357
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 472
Net Receivables 1,340
Inventory 57
Other Current Assets 0
Total Current Assets  (as reported)5,357
Total Current Assets  (calculated)1,869
+/- 3,488
Long-term Assets
Property Plant Equipment 1,840
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,840
+/- 1,840

Liabilities & Shareholders' Equity

Total Current Liabilities11,907
Long-term Liabilities0
Total Stockholder Equity-826
Total Current Liabilities
Short Long Term Debt 1,256
Accounts payable 497
Other Current Liabilities 172
Total Current Liabilities  (as reported)11,907
Total Current Liabilities  (calculated)1,926
+/- 9,982
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock50,608
Retained Earnings -66,804
Other Stockholders Equity 3,666
Total Stockholder Equity (as reported)-826
Total Stockholder Equity (calculated)-12,529
+/- 11,703
Other
Net Tangible Assets -6,658



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2009-03-312008-03-312007-03-312006-03-312005-03-312003-03-312002-03-312001-03-31
> Total Assets 
6,100
2,867
2,661
3,939
3,631
4,431
4,851
893
8934,8514,4313,6313,9392,6612,8676,100
   > Total Current Assets 
4,511
1,386
742
0
11,416
13,028
3,919
5,357
5,3573,91913,02811,41607421,3864,511
       Cash And Cash Equivalents 
4,215
278
545
745
1,144
1,089
2,249
472
4722,2491,0891,1447455452784,215
       Short-term Investments 
0
875
0
0
1,541
2,126
0
0
002,1261,541008750
       Net Receivables 
255
183
129
0
301
848
889
1,340
1,3408898483010129183255
       Inventory 
22
14
32
11
3
14
21
57
572114311321422
       Other Current Assets 
19
36
35
60
0
0
0
0
000060353619
   > Long-term Assets 00000000
       Property Plant Equipment 
1,575
1,469
1,475
2,253
2,583
2,462
2,195
1,840
1,8402,1952,4622,5832,2531,4751,4691,575
       Intangible Assets 
0
0
0
391
133
158
1
0
01158133391000
> Total Liabilities 
1,323
559
2,428
5,394
1,514
1,413
3,537
1,719
1,7193,5371,4131,5145,3942,4285591,323
   > Total Current Liabilities 
1,181
459
542
3,356
4,252
1,943
1,917
11,907
11,9071,9171,9434,2523,3565424591,181
       Short-term Debt 
37
42
41
0
0
0
0
0
00000414237
       Short Long Term Debt 
37
42
41
0
123
156
422
1,256
1,2564221561230414237
       Accounts payable 
1,145
415
471
323
478
575
648
497
4976485754783234714151,145
       Other Current Liabilities 
0
2
30
240
36
37
32
172
1723237362403020
   > Long-term Liabilities 00000000
       Deferred Long Term Liability 
0
0
0
0
183
361
0
0
003611830000
> Total Stockholder Equity
4,777
2,308
233
0
2,117
3,018
1,313
-826
-8261,3133,0182,11702332,3084,777
   Common Stock
11,575
11,470
12,473
19,419
39,902
49,881
49,881
50,608
50,60849,88149,88139,90219,41912,47311,47011,575
   Retained Earnings -66,804-53,865-43,966-35,8520-14,210-10,792-8,038
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
0
7
0
0
0
0
0
3,666
3,6660000070



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2009-03-31)

Gross Profit (+$)
totalRevenue5
Cost of Revenue-2
Gross Profit33
 
Operating Income (+$)
Gross Profit3
Operating Expense-990
Operating Income-985-987
 
Operating Expense (+$)
Research Development562
Selling General Administrative373
Selling And Marketing Expenses-
Operating Expense990935
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-985
Net Interest Income-
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,605-366
EBIT - interestExpense = -7,944
-1,605
-1,605
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-7,944-1,605
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,605
Tax Provision--
Net Income From Continuing Ops-1,605-1,605
Net Income-1,605
Net Income Applicable To Common Shares-12,939
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-6200
 

Technical Analysis of Biosyntech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biosyntech Inc. The general trend of Biosyntech Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biosyntech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biosyntech Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.003 < 0.003 < 0.003.

The bearish price targets are: 0.003 > 0.003 > 0.003.

Tweet this
Biosyntech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biosyntech Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biosyntech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biosyntech Inc.

Biosyntech Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiosyntech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biosyntech Inc. The current adx is .

Biosyntech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biosyntech Inc.

Biosyntech Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biosyntech Inc.

Biosyntech Inc Daily Relative Strength Index (RSI) ChartBiosyntech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biosyntech Inc.

Biosyntech Inc Daily Stochastic Oscillator ChartBiosyntech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biosyntech Inc.

Biosyntech Inc Daily Commodity Channel Index (CCI) ChartBiosyntech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biosyntech Inc.

Biosyntech Inc Daily Chande Momentum Oscillator (CMO) ChartBiosyntech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biosyntech Inc.

Biosyntech Inc Daily Williams %R ChartBiosyntech Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biosyntech Inc.

Biosyntech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biosyntech Inc.

Biosyntech Inc Daily Average True Range (ATR) ChartBiosyntech Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biosyntech Inc.

Biosyntech Inc Daily On-Balance Volume (OBV) ChartBiosyntech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biosyntech Inc.

Biosyntech Inc Daily Money Flow Index (MFI) ChartBiosyntech Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biosyntech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Biosyntech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biosyntech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.003
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biosyntech Inc with someone you think should read this too:
  • Are you bullish or bearish on Biosyntech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biosyntech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biosyntech Inc

I send you an email if I find something interesting about Biosyntech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biosyntech Inc.

Receive notifications about Biosyntech Inc in your mailbox!